Timelex
ActiveSummary
Timelex has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €44,021. Equity has been growing by about 5.7% per year since 2019. Its solvency ranks better than 52% of 4,124 sector peers (NACE 69, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 20-06-2007 Normal situation
- Registered office
- 182 active companies are registered at this address 10 started in the 12 months before. Source: KBO register, as of 3 November 2026.
- Activity
- Activities of lawyers NACE 69101
- Joint committee
- 336 Paritair Comité voor de vrije beroepen · annual accounts 30-06-2025
- Establishment unit
- 2.244.326.513 1000 Brussel, since 01-07-2015
- Financial year end
- 30 June
- Peppol
- Reachable since 21-10-2026
Board and ownership
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts to 30-06-2025
- Gross margin
- €309,276
- ▼ 1.4%
- Turnover
- ≈ €530,000
- estimated
- Profit
- €44,021
- ▼ 4.1%
- Equity
- €1.1m
- ▲ 4.3%
- Total assets
- €2.4m
- ▲ 5.5%
- Employees on 30-06-2025
- 4
- ▲ 33.3%
Score breakdownlowers riskLiquidity: current ratio 7.42, cash €1.1mSector: Legal and accounting activities (NACE 69)Figures for financial year 2025 (filed on 30-01-2026)Size: 3.6 FTE, total assets €2.4mShow the evidence
Checked score
Score 2025
93
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 48% of micro companies in legal and accounting (NACE 69)
Financial strength · tick: 2024
Strong
Solvency
71=
equity 45.9% of total assets
Liquidity
98+5
short-term debt 13.2% · cash 46.9%
Profitability
42-29
return on assets 1.9%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024highest value
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €100,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 7.42 (4.54 in 2024), above the usual 1.5. Short-term debt is 13.2% and cash 46.9% of total assets. However, 54.1% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 69, micro). It does better than 43% of them on solvency, 93% on liquidity, 9% on profitability and 46% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 day early
2024
on the day
2023
on the day
2022
4 days early
2021
on the day
2020
2 days early
2019
2 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 1 day before the deadline. In the sector (NACE 69), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 31 January (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
30-06-2026 year end03-11-2026 today31-01-2027 deadline
Financials
Financials · financial year 2025, abbreviated format
Annual accounts 2025 filed on 30-01-2026 PDF all 18 filings
Turnover
≈ €530,000
Estimated: probably between €440,000 and €660,000
Total assets
€2.4m▲ 5.5%
2024 · €2.2m
Net result
€44,021▼ 4.1%
2024 · €45,907
Working capital
€2.0m▲ 16.7%
2024 · €1.7m
Multi-year overview
2019 to 2025, 7 financial yearsOperating result
€60,879
▼ 14.7%
2025
20192025
Net result
€44,021
▼ 4.1%
2025
middle half of the sector
20192025
Equity
€1.1m
▲ 4.3%
2025
highest quarter of the sector
20192025
Total assets
€2.4m
▲ 5.5%
2025
highest quarter of the sector
20192025
Debt
€1.3m
▲ 6.6%
2025
20192025
Working capital
€2.0m
▲ 16.7%
2025
highest quarter of the sector
20192025
Solvency
45.9%
▼ 0.5pp
2025
middle half of the sector
20192025
Current ratio
7.42
▲ 2.87
2025
highest quarter of the sector
20192025
Return on assets (ROA)
1.9%
▼ 0.2pp
2025
lowest quarter of the sector
20192025
Staff (FTE)
3.6
▲ 9.1%
2025
middle half of the sector
20192025
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line2019202020212022202320242025
Operating result€0.1m-€0.08m▼ 38.1%€0.08m▲ 6.6%€0.09m▲ 11.4%€0.09m▼ 4.2%€0.07m▼ 17.6%€0.06m▼ 14.7%
Net result€0.08m-€0.05mwithin the sector's middle half▼ 39.5%€0.06mwithin the sector's middle half▲ 22.9%€0.06mwithin the sector's middle half▼ 0.1%€0.06mwithin the sector's middle half▼ 4.7%€0.05mwithin the sector's middle half▼ 18.0%€0.04mwithin the sector's middle half▼ 4.1%
Equity€0.8m-€0.8mabove the sector's middle half▲ 6.2%€0.9mabove the sector's middle half▲ 7.2%€0.9mabove the sector's middle half▲ 6.7%€1.0mabove the sector's middle half▲ 6.0%€1.0mabove the sector's middle half▲ 4.6%€1.1mabove the sector's middle half▲ 4.3%
Total assets€2.2m-€1.8mwithin the sector's middle half▼ 16.4%€2.1mwithin the sector's middle half▲ 15.2%€1.7mwithin the sector's middle half▼ 17.4%€3.3mabove the sector's middle half▲ 92.7%€2.2mwithin the sector's middle half▼ 33.2%€2.4mabove the sector's middle half▲ 5.5%
Debt€1.4m-€1.0m▼ 28.7%€1.2m▲ 21.6%€0.8m▼ 34.7%€2.3m▲ 194%€1.2m▼ 49.1%€1.3m▲ 6.6%
Working capital€0.9m-€1.0mabove the sector's middle half▲ 12.4%€1.7mabove the sector's middle half▲ 62.1%€1.3mabove the sector's middle half▼ 23.9%€2.5mabove the sector's middle half▲ 101%€1.7mabove the sector's middle half▼ 32.4%€2.0mabove the sector's middle half▲ 16.7%
Solvency35.2%-44.8%within the sector's middle half▲ 9.5pp41.7%within the sector's middle half▼ 3.1pp53.9%within the sector's middle half▲ 12.2pp29.6%within the sector's middle half▼ 24.2pp46.4%within the sector's middle half▲ 16.8pp45.9%within the sector's middle half▼ 0.5pp
Current ratio1.81-2.46within the sector's middle half▲ 0.645.46above the sector's middle half▲ 3.003.92above the sector's middle half▼ 1.544.29above the sector's middle half▲ 0.374.54above the sector's middle half▲ 0.257.42above the sector's middle half▲ 2.87
Return on assets (ROA)3.6%-2.6%within the sector's middle half▼ 1.0pp2.8%within the sector's middle half▲ 0.2pp3.4%within the sector's middle half▲ 0.6pp1.7%below the sector's middle half▼ 1.7pp2.1%below the sector's middle half▲ 0.4pp1.9%below the sector's middle half▼ 0.2pp
Staff (FTE)1.2-2.9within the sector's middle half▲ 142%3.3within the sector's middle half▲ 13.8%3within the sector's middle half▼ 9.1%3.3within the sector's middle half▲ 10.0%3.3within the sector's middle half=3.6within the sector's middle half▲ 9.1%
above
within
below
The sector band is the middle half of the companies in Legal and accounting activities (NACE 69). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
The operating result for 2025 is 15% lower than in 2024 and the lowest since 2021. It is the third fall in a row.
Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.4m
Fixed assets
€42,345 ▲ 23.8%
Current assets
€2.3m ▲ 5.2%
Equity and liabilities €2.4m
Equity
€1.1m ▲ 4.3%
Debt
€1.3m ▲ 6.6%
Debt's share of the balance-sheet total rises from 53.6% to 54.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€73,282▼
2024 · €83,654
Cash flow
€56,423▼
2024 · €58,224
Debt to equity
1.18▲
2024 · 1.15
ROE
4.1%▼
2024 · 4.4%
Debt ≤ 1 year
€311,227▼
2024 · €482,917
Income taxes
€19,638▼
2024 · €26,212
Staff costs
€234,939▲
2024 · €228,915
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Staff
| Item | 30-06-2022 | 30-06-2023 | 30-06-2024 | 30-06-2025 |
|---|---|---|---|---|
| Employees at the balance-sheet date | 3 | 4 | 3 | 4 |
| full-time | 3 | 3 | 3 | 3 |
| part-time | - | 1 | - | 1 |
| in full-time equivalents | 3 | 3.8 | 3 | 3.4 |
| Average over the year, in full-time equivalents | 2.8 | 3.3 | 3.3 | 3.6 |
| On a permanent contract | 3 | 4 | 3 | 3 |
| Joined | 4 | 2 | 6 | 8 |
| Left | 4 | 1 | 7 | 7 |
Source: social balance sheet in the 2022 to 2025 annual accounts
Investments
| Item | 30-06-2022 | 30-06-2023 | 30-06-2024 | 30-06-2025 |
|---|---|---|---|---|
| Tangible fixed assets | €10,155 | €15,312 | €10,476 | €20,545 |
| Depreciation and write-downs of the year | €39,771 | €21,031 | €12,317 | €12,403 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
Subsidies and aid
European Union, budget
2021 to 2025 · 81 entries · €8.3m in total| Year | Entries | Awarded |
|---|---|---|
| 2025 | 9 | €1.2m |
| 2024 | 11 | €1.3m |
| 2023 | 17 | €1.8m |
| 2022 | 29 | €3.3m |
| 2021 | 15 | €0.6m |
Projects
AISYM4MED - SYNTHETIC AND SCALABLE DATA PLATFORM FOR MEDICAL EMPOWERED AI
CARAMEL - CARDIOVASCULAR RISK ASSESSMENT IN MENOPAUSAL WOMEN VIA MULTIMODAL DATA ANALYSIS ENABLING PERSONALIZED PREVENTION STRATEGIES
POSEIDON - POST-QUANTUM SECURE DIGITAL IDENTITIES FOR EUROPEAN SOLUTIONS
PREVENT - IMPROVING AND UPSCALING PRIMARY PREVENTION OF CANCER BY ADDRESSING CHILDHOOD OBESITY THROUGH IMPLEMENTATION RESEARCH - THE PREVENT APPROACH
CYCLOPS - AUTOMATED END-TO-END DATA LIFE CYCLE MANAGEMENT FOR FAIR DATA INTEGRATION, PROCESSING AND RE-USE
Show 28 more projects
101073949 2PS PREVENT & PROTECT THROUGH SUPPORT AIMS TO OFFER A PARADIGM SHIFT IN THE APPROACH TACKLING CHILD SEXUAL ABUSE AND EXPLOITATION ACROSS EUROPE WITH PREVENTIVE ACTIONS ADDRESSING PEOPLE WHO ARE OR COULD BE A THREAT TO CHILDREN
DISARMING THE SILENT THREAT OF OVARIAN CANCER
VOLABIOS - VALIDATION AND COMPARITIVE MULTI-OMICS BENCHMARKING OF FLUID-DERIVED VOLATILOMICS BIOMARKERS FOR THE PREVENTION AND EARLY DETECTION OF SCHIZOPHRENIA
RES-Q PLUS - COMPREHENSIVE SOLUTIONS OF HEALTHCARE IMPROVEMENT BASED ON THE GLOBAL REGISTRY OF STROKE CARE QUALITY
TRUMPET - TRUSTWORTHY MULTI-SITE PRIVACY ENHANCING TECHNOLOGIES
ENDURANCE - STRATEGIES AND SERVICES FOR ENHANCED DISRUPTION RESILIENCE AND COOPERATION IN EUROPE
LETS CARE - LETS CARE: BUILDING SAFE AND CARING SCHOOLS TO FOSTER EDUCATIONAL INCLUSION AND SCHOOL ACHIEVEMENT
EMPOWERING AND CONNECTING DIVERSE COMMUNITIES FOR MULTI-HAZARD RESILIENCE WITH OPEN DATA, OPEN MODELS, AND OPEN-SOURCE SOFTWARE
FLUTE - FEDERATE LEARNING AND MULTI-PARTY COMPUTATION TECHNIQUES FOR PROSTATE CANCER
TRIDENT - TECHNOLOGY BASED IMPACT ASSESSMENT TOOL FOR SUSTAINABLE, TRANSPARENT DEEP SEA MINING EXPLORATION AND EXPLOITATION
AI4LUNGS - AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION
REBECCA - RESEARCH ON BREAST CANCER INDUCED CHRONIC CONDITIONS SUPPORTED BY CAUSAL ANALYSIS OF MULTI-SOURCE DATA
TRACY - A BIG-DATA ANALYTICS FROM BASE-STATIONS REGISTRATIONS AND CDRS E-EVIDENCE SYSTEM
CONVINCE - CONTEXT-AWARE VERIFIABLE DYNAMIC DELIBERATION
ONCOSCREEN - A EUROPEAN SHIELD AGAINST COLORECTAL CANCER BASED ON NOVEL, MORE PRECISE AND AFFORDABLE RISK-BASED SCREENING METHODS AND VIABLE POLICY PATHWAYS
TOLIFE - COMBINING ARTIFICIAL INTELLIGENCE AND SMART SENSING TOWARD BETTER MANAGEMENT AND IMPROVED QUALITY OF LIFE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
INCIDENTRON - MASTERING INCIDENT RESPONSE THROUGH AN OPEN SOURCE FRAMEWORK, ARCHITECTURE, AND PLATFORM
DOME - A DISTRIBUTED OPEN MARKETPLACE FOR EUROPE CLOUD AND EDGE SERVICES
LUCIA - UNDERSTANDING LUNG CANCER RELATED RISK FACTORS AND THEIR IMPACT
AIRCARE - AI-AUGMENTED ROBOTICS FOR CANCER POINT OF CARE
CYBERSEAS - CYBERSEAS: CYBER SECURING ENERGY DATA SERVICES
GLIOMATCH - THE MALIGNANT GLIOMA IMMUNO-ONCOLOGY MATCHMAKER: TOWARDS DATA-DRIVEN PRECISION MEDICINE USING SPATIALLY RESOLVED RADIO-MULTIOMICS
IMPACT- AML - MASTER FRAMEWORK AND PRAGMATIC CLINICAL TRIAL FOR RELAPSE OR REFRACTORY ACUTE MYELOID LEUKEMIA
KOBAN - IDENTIFYING FUTURE CAPABILITIES FOR COMMUNITY POLICING
TRUSTCHAIN - FOSTERING A HUMAN-CENTERED, TRUSTWORTHY AND SUSTAINABLE INTERNET
HOPLITE THREAT DETECTION AND INTELLIGENCE SHARING
AVIATOR PHASE 2 - AVIATOR - AUGMENTED VISUAL INTELLIGENCE AND TARGETED ONLINE RESEARCH
REGACE - CROP RESPONSIVE GREENHOUSE AGRIVOLTAICS SYSTEM WITH CO2 ENRICHMENT FOR HIGHER YIELDS
European research
65 projects · €14.9m EU contributionProgrammes
Projects
Mechanism-Informed Multimodal Generative AI for Causal and Dynamical Modelling in Biomedical Research
Synthetic and scalable data platform for medical empowered AI
Central Repository for Digital Pathology
AI-GENERATED DIGITAL TWIN INFRASTRUCTURE FOR HEALTHCARE & LIVING ENVIRONMENT
CArdiovascular Risk Assessment in MEnopausaL women via multimodal data analysis enabling personalized prevention strategies
Show 35 more projects
Improving and upscaling primary prevention of cancer by addressing childhood obesity through implementation research - the PREVENT approach
EMPOWERING AND EDUCATING YOUNG PEOPLE FOR THE INTERNET BY PLAYING
A multimodal AI-based toolbox and an interoperable health imaging repository for the empowerment of imaging analysis related to the diagnosis, prediction and follow-up of cancer
AEGLE (Ancient Greek: Αἴγλη) – An analytics framework for integrated and personalized healthcare services in Europe
POst-quantum SEcure dIgital iDentities for EurOpean solutioNs
FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE
Federate Learning and mUlti-party computation Techniques for prostatE cancer
Lightweight Infrastructure for Global Heterogeneous Trust management in support of an open Ecosystem of Stakeholders and Trust schemes.
Disarming the silent threat of ovarian cancer
Understanding Lung Cancer related risk factors and their Impact
Validation and Comparitive Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early detection of Schizophrenia
Automated end-to-end data life cycle management for FAIR data integration, processing and re-use
2PS - Prevent & Protect Through Support
Comprehensive solutions of healthcare improvement based on the global Registry of Stroke Care Quality
From mobile phones to court – A complete FORensic investigation chain targeting MOBILE devices
TRUstworthy Multi-site Privacy Enhancing Technologies
KONFIDO - Secure and Trusted Paradigm for Interoperable eHealth Services
ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY
Design of the European mobile network operator for research
AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION
A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways
DEvOps for trusted, portable and interoperable Multi-Cloud applications towards the Digital singlE market
Strategies and Services for Enhanced Disruption Resilience and Cooperation in Europe
Mobile Cross-Border Government Services for Europe
The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics
Empowering and Connecting Diverse Communities for Multi-Hazard Resilience with Open Data, Open Models, and Open-Source Software
Technology based impact assessment tool foR sustaInable, transparent Deep sEa miNing exploraTion and exploitation
REsearch on BrEast Cancer induced chronic conditions supported by Causal Analysis of multi-source data
Digital Europe for All
NOVEL INTEGRATED SOLUTION OF OPERATING A FLEET OF DRONES WITH MULTIPLE SYNCHRONIZED MISSIONS FOR DISASTER RESPONSES
A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment.
Next-Generation Visuohaptic Media Representation, Coding and Interactive Rendering for Immersive and Inclusive XR
implemented SynergIes, data sharing contracts and Goals between transport modes and AIR tansportation
CONtext-aware VerifIable dyNamiC dEliberation
Combining Artificial Intelligence and smart sensing TOward better management and improved quality of LIFE in chronic obstructive pulmonary disease
Public contracts
5 awards · 2022 to 2026
Juridische adviesverlening en ondersteuning.: 2025/HFB/VOPMB/139729 - 6
Juridische adviesverlening en ondersteuning.: 2025/HFB/VOPMB/139729 - 7
Supporting ENISA in ensuring Cyber Resilience of the EU: Cybersecurity Support and Compliance for SMEs under the Cyber Resilience Act
Procédure ouverte pour la « prestation de services juridiques par des avocats dans des procédures devant la Chambre contentieuse de l'Autorité de protection des données et la Cour des marchés »: Nederlandstalige zaken
2021/HFB/VOPMB/80868 - Raamovereenkomst voor juridische ondersteuning.: Perceel 6
Source: TED (Tenders Electronic Daily), Publications Office of the European Union. The values are as the buyer published them. For a framework agreement, the value is a ceiling.
Annual accounts
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | €184,246 | €220,159 | €228,915 | €234,939 | ▲ 2.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €72,577 | €62,820 | €43,372 | €39,771 | €21,031 | €12,317 | €12,403 | ▲ 0.7% |
| Other operating charges640/8 | - | - | - | €1,083 | €84,024 | €1,045 | €1,055 | ▲ 0.9% |
| Gross operating margin9900 | €266,009 | €284,349 | €332,453 | €315,440 | €411,782 | €313,614 | €309,276 | ▼ 1.4% |
| Operating profit (loss)9901 | €122,934 | €76,073 | €81,110 | €90,340 | €86,569 | €71,338 | €60,879 | ▼ 14.7% |
| Financial income75/76B | - | - | - | €938 | €1,951 | €2,267 | €2,780 | ▲ 22.6% |
| Recurring financial income75 | €21 | €1,028 | €691 | €938 | €1,951 | €2,267 | €2,780 | ▲ 22.6% |
| Financial charges65/66B | - | - | - | €2,989 | €2,531 | €1,485 | - | - |
| Recurring financial charges65 | €2,375 | €35 | €176 | €2,989 | €2,531 | €1,485 | - | - |
| Profit (loss) for the period before taxes9903 | €120,581 | €77,067 | €81,625 | €88,288 | €85,989 | €72,120 | €63,659 | ▼ 11.7% |
| Income taxes67/77 | €41,427 | €29,214 | €22,823 | €29,533 | €30,021 | €26,212 | €19,638 | ▼ 25.1% |
| Profit (loss) for the period9904 | €79,154 | €47,852 | €58,802 | €58,755 | €55,968 | €45,907 | €44,021 | ▼ 4.1% |
| Profit (loss) for the period to be appropriated9905 | €79,154 | €47,852 | €58,802 | €58,755 | €55,968 | €45,907 | €44,021 | ▼ 4.1% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €2.2m | €1.8m | €2.1m | €1.7m | €3.3m | €2.2m | €2.4m | ▲ 5.5% |
| Fixed assets21/28 | €0.1m | €0.1m | €0.07m | €0.04m | €0.04m | €0.03m | €0.04m | ▲ 23.8% |
| Tangible fixed assets22/27 | €0.1m | €0.09m | €0.06m | €0.03m | €0.02m | €0.02m | €0.03m | ▲ 36.9% |
| Plant, machinery and equipment23 | - | - | - | €0.01m | €0.02m | €0.02m | €0.02m | ▲ 43.6% |
| Furniture and vehicles24 | - | - | - | €0.008m | €0.005m | €0.004m | €0.002m | ▼ 41.3% |
| Leasing and similar rights25 | - | - | - | €0.01m | €0.002m | €0.001m | €0.003m | ▲ 203% |
| Financial fixed assets28 | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | = |
| Current assets29/58 | €2.0m | €1.7m | €2.0m | €1.7m | €3.3m | €2.2m | €2.3m | ▲ 5.2% |
| Amounts receivable within one year40/41 | €1.3m | €0.9m | €0.8m | €0.9m | €1.4m | €1.3m | €1.2m | ▼ 6.8% |
| Trade receivables40 | - | - | - | €0.8m | €1.2m | €1.1m | €1.1m | ▲ 1.0% |
| Other amounts receivable41 | - | - | - | €0.08m | €0.2m | €0.2m | €0.1m | ▼ 48.1% |
| Current investments50/53 | - | - | - | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Cash at bank and in hand54/58 | €0.7m | €0.8m | €1.3m | €0.8m | €1.9m | €0.9m | €1.1m | ▲ 22.1% |
| Deferred charges and accrued income490/1 | - | - | - | - | - | - | €0.002m | - |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €2.2m | €1.8m | €2.1m | €1.7m | €3.3m | €2.2m | €2.4m | ▲ 5.5% |
| Equity10/15 | €0.8m | €0.8m | €0.9m | €0.9m | €1.0m | €1.0m | €1.1m | ▲ 4.3% |
| Contributions10/11 | €0.006m | €0.006m | - | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Reserves13 | €0.8m | €0.8m | €0.9m | €0.9m | €1.0m | €1.0m | €1.1m | ▲ 4.3% |
| Non-distributable reserves130/1 | - | - | - | €0.002m | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.002m | - | - | - | - |
| Distributable reserves133 | - | - | - | €0.9m | €1.0m | €1.0m | €1.1m | ▲ 4.3% |
| Amounts payable17/49 | €1.4m | €1.0m | €1.2m | €0.8m | €2.3m | €1.2m | €1.3m | ▲ 6.6% |
| Amounts payable within one year42/48 | €1.1m | €0.7m | €0.4m | €0.4m | €0.8m | €0.5m | €0.3m | ▼ 35.6% |
| Trade debts44 | €1.1m | €0.7m | €0.3m | €0.4m | €0.7m | €0.5m | €0.3m | ▼ 37.4% |
| Suppliers440/4 | - | - | - | €0.4m | €0.7m | €0.5m | €0.3m | ▼ 37.4% |
| Taxes, remuneration and social security45 | - | - | - | €0.03m | €0.04m | €0.02m | €0.02m | ▲ 3.6% |
| Taxes450/3 | - | - | - | €0.01m | €0.01m | €0.006m | - | - |
| Remuneration and social security454/9 | - | - | - | €0.02m | €0.03m | €0.02m | €0.02m | ▲ 39.2% |
| Accrued charges and deferred income492/3 | - | - | - | €0.4m | €1.6m | €0.7m | €1.0m | ▲ 35.2% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.08m | €0.05m | €0.06m | €0.06m | €0.06m | €0.05m | €0.04m | ▼ 4.1% |
| + Depreciation and write-downs630 | €0.07m | €0.06m | €0.04m | €0.04m | €0.02m | €0.01m | €0.01m | ▲ 0.7% |
| Operating cash flow (approximation) | €0.2m | €0.1m | €0.1m | €0.1m | €0.08m | €0.06m | €0.06m | ▼ 3.1% |
| Investment in fixed assets (approximation) | - | -€0.01m | -€0.02m | -€0.01m | -€0.02m | -€0.01m | -€0.02m | ▼ 96.1% |
| Change in cash | - | €0.09m | €0.5m | -€0.5m | €1.1m | -€1.0m | €0.2m | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 10,904 companies had the same profile as Timelex has now. Two years later, 95.1% were still going and 0.7% had gone bankrupt.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit under 5% of the balance sheet
95.1%
was still going
4.0%
stopped otherwise
0.7%
went bankrupt
That fits the bankruptcy probability of Timelex itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 10,904 companies, not a prediction for Timelex. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Latest 10 of 18 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 30-06-2025 | abbreviated format | 30-01-2026 | 2026-00021428 | |
| 30-06-2024 | abbreviated format | 31-01-2025 | 2025-00017908 | |
| 30-06-2023 | abbreviated format | 31-01-2024 | 2024-00015505 | |
| 30-06-2022 | abbreviated format | 27-01-2023 | 2023-00006073 | |
| 30-06-2021 | abbreviated format | 31-01-2022 | 2022-03500407 | |
| 30-06-2020 | abbreviated format | 29-01-2021 | 2021-02900195 | |
| 30-06-2019 | abbreviated format | 29-01-2020 | 2020-02700155 | |
| 30-06-2018 | abbreviated format | 31-01-2019 | 2019-03700339 | |
| 30-06-2017 | abbreviated format | 31-01-2018 | 2018-03700519 | |
| 30-06-2016 | abbreviated format | 30-01-2017 | 2017-03000025 |
Board & ownership
Directors
Directors
4 directors
Edwin Jacobs BV
Current
Director · Legal entity · listed in the 2025 annual accounts, filed on 30-01-2026
Geert Somers Legal BV
Current
Director · Legal entity · listed in the 2025 annual accounts, filed on 30-01-2026
Graux-ITLaw BV
Current
Director · Legal entity · listed in the 2025 annual accounts, filed on 30-01-2026
Joseph Dumortier BV
Current
Director · Legal entity · listed in the 2025 annual accounts, filed on 30-01-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 10-02-2022Owners and capital
Owners
Mandate history
4 people, 4 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Edwin Jacobs BV |
|
| Geert Somers Legal BV |
|
| Graux-ITLaw BV |
|
| Joseph Dumortier BV |
|
Network & group
Timelex shares no director with another company.
Companies at the same address
181 other companies- Christou, Athanasios (sole trader) Establishment · since 2026 1044328823
- FND Finance Registered office · since 2026 1042897676
- Frédéric, Lola (sole trader) Establishment · since 2026 1041484842
- SDA-Tech Registered office · since 2026 1040607288
- Makougoum Fongang, Lauriana (sole trader) Establishment · since 2026 1028685295
- Velqorin Registered office · since 2026 1036002857
- Action Languages / Action Psychology Registered office · since 2026 1035032065
- Prospera Alpha Ventures Registered office · since 2026 1033964471
- Phoenix Defense Community Registered office · since 2026 1033244889
- BENOIT KOHL AVOCAT Establishment · since 2026 0685811774
Connections & network
4 current directorsThe network starts from the directors of Timelex. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
30-01
abbreviated format · 1 day before the deadline
2025
31-01
abbreviated format · on the deadline day
2024
30-06
Financial
Equity above €1mequity €1.0m ▲4.6%
With a profit in every financial year since 2019, equity grows to €1.0m.
31-01
abbreviated format · on the deadline day
2023
27-01
abbreviated format · 4 days before the deadline
2022
10-02
Gazette deed
Company renamed to TimelexLegal-form conversion · Capital conversion · Amendment of the articles9 points ▸
Gazette deed
Company renamed to Timelex
Legal-form conversion · Capital conversion · Amendment of the articles9 points ▸
- General meeting, 19-01-2022
- Other provision, “aanpassing statuten aan WVV, statuten aanpassen aan bepalingen WVV” (deed in Dutch)
- Legal-form conversion, “besloten vennootschap” (deed in Dutch)
- Capital conversion, “middelen beschikbaar voor uitkering”, EUR (deed in Dutch)
- Name change, Timelex
- Amendment of the articles
- Kind of shares, “houders soort A bepalen uitgifteprijs,te storten bedrag,tijdstippen opvraging en rente, Soort A” (deed in Dutch)
- Power of attorney
- Registered office clause, “1000 Brussel,Joseph Stevensstraat” (deed in Dutch)
31-01
abbreviated format · on the deadline day
2021
30-06
Financial
Liquidity more than doubledcurrent ratio 5.46
The current ratio rises from 2.46 to 5.46. Short-term debt falls from €700,995 to €371,037.
29-01
abbreviated format · 2 days before the deadline
2020
29-01
abbreviated format · 2 days before the deadline
2019
31-01
abbreviated format · on the deadline day
2018
31-01
abbreviated format · on the deadline day
2017
30-01
abbreviated format · 1 day before the deadline
2007
29-06
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
Timelex in Dutch
Enterprise number
0890.217.005
Legal form
Private limited company
Status
Active, normale toestand
Founded
20-06-2007
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 10-02-2022 (in Dutch)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Brussels Hoofdstedelijk Gewest, bestuursorgaan kan bijkantoren en centra oprichten in België en buitenland”
deed of 10-02-2022 (in Dutch)Registered office and establishments
Registered office
Joseph Stevensstraat 7, 1000 Brussel, Belgium
Establishment unit
Joseph Stevensstraat 7, 1000 Brussel since 01-07-2015 · unit number 2.244.326.513
Activities
NACEBEL 2025VAT activities
69101
Activities of lawyers main activity
Social security (RSZ) activities
69101
Activities of lawyers main activity
Codes under NACEBEL 2008
VAT activities
69101
Activities of lawyers main activity
Social security (RSZ) activities
69101
Activities of lawyers main activity
Joint committee
336 Paritair Comité voor de vrije beroepen annual accounts 30-06-2025
Invoicing and payment
VAT number
BE 0890.217.005
Financial year and general meeting
Accounts at the NBBFinancial year end
30-06
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
30 November at 15:00
deed of 10-02-2022 (in Dutch)Sites & property
Location
Buildings and parcels at the address
Ground area
2,159 m²
Building footprint
2,113 m²
Building volume
79,173 m³
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21808H1372/00K000 | Brussels | 2,159 m² | 1 · 2,113 m² | 88.8 m · 7 |